Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS label_change · 2026-04-13Clinical Trial Update: Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating the combination of trastuzumab deruxtecan (DS-8201a) and azenosertib (ZN-c3) in gastric and gastroesophage…
-
FDA label_change · 2025-06-27FDA Approved: PERJETA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for PERJETA (pertuzumab) from Genentech, Inc., resulting in updated labeling under the existing appr…
-
FDA label_change · 2020-03-19FDA Approved: ONTRUZANT — Supplemental Application (Organon LLC)
FDA approves a supplemental application for ONTRUZANT (trastuzumab) filed by Organon LLC, resulting in changes to the product labeling.
-
FDA label_change · 2013-06-26FDA Approved: DOCETAXEL — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for docetaxel, resulting in changes to the product labeling. The changes may include updates to indi…